Assisted Reproduction Center, Northwest Women's and Children's Hospital Affiliated to Xi'an Jiaotong University, 73#, Houzaimen North Street, Xi'an, People's Republic of China.
Leuven Institute for Fertility & Embryology, Schipvaartstraat 4, 3000, Leuven, Belgium.
J Assist Reprod Genet. 2020 Aug;37(8):1883-1893. doi: 10.1007/s10815-020-01828-0. Epub 2020 May 21.
To evaluate reproductive outcomes of artificial insemination and IVF with donor sperm (AID or IVF-D) for male-factor couples with a history of unsuccessful ICSI attempt.
This retrospective cohort includes couples with severe male-factor infertility who failed ICSI treatment, and subsequently underwent semen donation treatment. We report the following outcomes: (1) live birth rates in AID and IVF-D treatment for couples with severe male infertility factors and prior ICSI failures; (2) paternal impact on embryo development of the same oocyte cohort; (3) prognostic factors in obtaining a live birth with donor semen.
Of 92 women with failed ICSI cycles (26 with multiple attempts), 45 couples underwent AID treatment. Live birth rate per cycle of AID was 18.9%. Fifty-three patients underwent IVF-D including 6 couples who previously did not conceive with AID. Embryological outcomes including fertilization, viable cleavage embryos, and blastocyst formation rates were significantly lower in ICSI cycles with partner sperm compared with IVF-D (P < 0.01). Logistic regression analysis showed that female age and the severity of spermatogenetic disorder are prognostic factors in obtaining a live birth with donated sperm.
Couples with severe male infertility factor (azoospermia or extreme oligoasthenospermia) and a history of unsuccessful ICSI cycles benefit from treating with donor sperm. ICSI fertilization, embryo viability, and progression of the embryo to the blastocyst stage are significantly deteriorated by semen parameters. The prognostic factors identified may help couples plan their treatment and prepare for their parenthood journey.
评估有男性因素不孕史且 ICSI 失败史的夫妇接受供精人工授精(AID)或体外受精-胚胎移植(IVF-D)的生殖结局。
本回顾性队列纳入了因严重男性因素不孕且 ICSI 治疗失败而接受精液捐献治疗的夫妇。我们报告了以下结局:(1)严重男性因素不育且 ICSI 失败的夫妇接受 AID 和 IVF-D 治疗的活产率;(2)同一卵母细胞队列中父系对胚胎发育的影响;(3)用供精获得活产的预测因素。
在 92 名 ICSI 周期失败的女性(26 名接受多次尝试)中,有 45 对夫妇接受了 AID 治疗。AID 治疗的每个周期活产率为 18.9%。53 名患者接受了 IVF-D 治疗,其中 6 对夫妇之前接受 AID 治疗未怀孕。与 IVF-D 相比,ICSI 周期中伴侣精子的受精、可存活卵裂胚胎和囊胚形成率显著降低(P<0.01)。Logistic 回归分析显示,女性年龄和生精障碍严重程度是用供精获得活产的预测因素。
有严重男性因素不孕(无精子症或严重少弱精子症)和 ICSI 周期失败史的夫妇受益于接受供精治疗。ICSI 受精、胚胎活力以及胚胎向囊胚阶段的进展因精液参数而显著恶化。确定的预测因素可以帮助夫妇规划他们的治疗并为他们的育儿之旅做好准备。